Answers are grounded in this paper and cite their sources.
Key Points Nanomolar concentrations of drag-reducing polymer (DRP) reduce vaso-occlusion in the liver of sickle cell disease (SCD) mice. The potential for DRP as a rheology-based treatment/therapy for SCD warrants further study.
No takes yet. Share an insight, caveat, or question.
Crompton et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: